NCT04119024 2026-03-17Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsStanford UniversityPhase 1 Recruiting18 enrolled
NCT05952947 2024-02-02HRYZ-T101 Injection for HPV18 Positive Solid TumorHRYZ Biotech Co.Phase 1 Recruiting32 enrolled